02666.HK
Genertec Universal Medical Group Company Limited
HKSE · Financial Services · Financial - Credit Services · CN
HKD 4.53
+1.57%Year over year
Reported trailing growth
- Revenue
- -2.6%
- EBITDA
- +178.1%
- EBIT
- -72.6%
- EPS
- +0.0%
- Free cash flow
- -75.3%
- Operating cash flow
- -61.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +7.9%
- EBITDA
- +6.8%
- EBIT
- +7.0%
- Net income
- +4.1%
- EPS
- +2.6%
- Free cash flow
- +28.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026